Nicotinic Acetylcholine R alpha 10/CHRNA10 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-86730
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the N-terminal region of Human Nicotinic Acetylcholine R alpha 10/CHRNA10. Peptide sequence: GGLDAIRIPSSLVWRPDIVLYNKADAQPPGSASTNVVLRHDGAVRWDAPA The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for Nicotinic Acetylcholine R alpha 10/CHRNA10 Antibody
Western Blot: Nicotinic Acetylcholine R alpha 10/CHRNA10 Antibody [NBP2-86730]
Western Blot: Nicotinic Acetylcholine R alpha 10/CHRNA10 Antibody [NBP2-86730] - Host: Rabbit. Target Name: CHRNA10. Sample Type: 721_B Whole Cell lysates. Antibody Dilution: 1.0ug/mlApplications for Nicotinic Acetylcholine R alpha 10/CHRNA10 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: Nicotinic Acetylcholine R alpha 10/CHRNA10
Long Name
Nicotinic Acetylcholine Receptor alpha 10
Alternate Names
CHRNA10, NACHRA10, Nicotinic Acetylcholine Ra10
Gene Symbol
CHRNA10
Additional Nicotinic Acetylcholine R alpha 10/CHRNA10 Products
Product Documents for Nicotinic Acetylcholine R alpha 10/CHRNA10 Antibody
Product Specific Notices for Nicotinic Acetylcholine R alpha 10/CHRNA10 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...